An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients

Colston, E; Grasela, D; Gardiner, D; Bucy, RP; Vakkalagadda, B; Korman, AJ; Lowy, I

Colston, E (reprint author), Bristol Myers Squibb, Innovat Med Dev, Princeton, NJ 08540 USA.

PLOS ONE, 2018; 13 (6):

Abstract

Expression of cytotoxic T-lymphocyte antigen 4 (CTLA-4), a negative regulator of T-cell function, is increased in chronic HIV-1 infection. It was hypo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索